METRONIDAZOLE
| Brand name | NUVESSA |
|---|---|
| Active ingredient | METRONIDAZOLE |
| Strength | 1.3% |
| Dosage form | GEL |
| Route | VAGINAL |
| Modality | Small molecule |
| FDA approval | March 2014 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 10238634 | June 2032 | product |
| 8946276 | June 2032 | use U-1664 |
| 9198858 | June 2032 | use U-1664 |
| 10596155 | June 2032 | product |
| 8658678 | June 2028 | use U-1682 |
| 7893097 | February 2028 | product |
| 8877792 | February 2028 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.